2012 Research Articles

Pathophysiology

• The effects of methane and hydrogen gases produced by enteric bacteria on ileal motility and colonic transit time.  PMID: 22097886
  

Causes/Risk Factors

• The migrating motor complex: control mechanisms and its role in health and disease. PMID: 22450306
• Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis. PMID: 23270866
• PPI use and SIBO: predisposition or cause?  PMID: 23211857

• Proton-pump inhibitor therapy and small bowel bacterial contamination.  PMID:22890175
• Ileocecal valve dysfunction in small intestinal bacterial overgrowth: a pilot study.  PMID: 23239918

Associated Diseases

• Evaluation of small intestine bacterial overgrowth in patients with functional dyspepsia through H2 breath test. PMID: 23329223
• Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome? PMID: 23272525
• [Predominance of constipation in subjects with hydrogen-consuming intestinal flora]. - Spanish  PMID: 23214347
• Small intestinal bacterial overgrowth in gastroparesis.  PMID:23053897
• Erosive esophagitis may be related to small intestinal bacterial overgrowth.  PMID: 22416969

Symptoms

• Comparison of abdominal bloating severity between Irritable Bowel Syndrome patients with high and low levels of breath hydrogen excretion in a lactulose breath test.  PMID: 22658548

Testing

• Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.  PMID: 22472730

Antibiotic Treatment: Rifaximin

• Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months.  PMID:23066911
• Antibiotics for irritable bowel syndrome: rationale and current evidence. PMID: 22945316
• Rifaximin and lubiprostone: the best options for treating irritable bowel syndrome?  PMID: 22816171
• Impurity profile of rifaximin produced in China.  PMID: 22570932
• Rifaximin for the treatment of irritable bowel syndrome.  PMID: 22251066
• Rifaximin Therapy of Irritable Bowel Syndrome.  PMID: 24833932
• The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis.  PMID: 22045120
• Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn's disease.  PMID:  22155172

Probiotics

• [Lactase deficiency in patients with postinfectious irritable bowel syndrome and the role of intestinal microflora in its development]. – in Russian  PMID: 23402179

Microbiome

• The gut microbiota and irritable bowel syndrome: friend or foe?  PMID: 22577594
• The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome.  PMID: 22262197

Low FODMAP DIET

• Dietary modification as a treatment for irritable bowel syndrome.  PMID: 23293571
• Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome.  PMID: 24672410
• Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?  PMID: 22778791
• Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.  PMID: 22739368
• Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome.  PMID: 22446969
• The role of diet in the pathogenesis and management of irritable bowel syndrome (Review).  PMID: 22366773

Diet & IBS

• Diet and irritable bowel syndrome.  PMID: 23256117
• IgG-based elimination diet in migraine plus irritable bowel syndrome.  PMID: 23216231
• Diet in subjects with irritable bowel syndrome: a cross-sectional study in the general population.  PMID: 22676475
• The value of eliminating foods according to food-specific immunoglobulin G antibodies in irritable bowel syndrome with diarrhoea.  PMID: 22429360

15% Off All Supplements at Fullscript

If you value this website, consider supporting the free information provided on siboinfo.com and it's newsletter, which helps SIBO sufferers world wide.

Site author:  Dr Allison Siebecker